CrushSCI.com
65.5Average days
60Median days
24Fastest days
149Longest days
2052025 publications

Paper Review Records

All Paper Review Records

13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

45 days

Infarcted tenosynovial giant cell tumors: Multi-institutional analysis of 80 cases highlighting consultation patterns and diagnostic challenges

Authors
John M. Gross; Olena Koshyk; Yin P. Hung; G. Petur Nielsen; Ivan A. Chebib; Scott R. Lauer; John D. Reith; Michael Michal; David I. Suster; Aaron W. James; Ezra G. Baraban; Nika Tavberidze; Gregory W. Charville; Andrew E. Rosenberg; Andrew L. FolpeShow moreShow less
Affiliations
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Medical Laboratory CSD, Ltd, Kyiv, Ukraine; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Pathology, University of Nebraska Medical Center, Omaha, NE, USA; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA; Department of Pathology, Charles University, Faculty of Medicine, Plzen, Czech Republic; Bioptical Laboratory, Ltd. Plzen, Czech Republic; Department of Pathology, Rutgers University, New Jersey Medical School, Newark, NJ, USA; Department of Pathology, University of Wisconsin, Madison, WI, USA; Department of Pathology, Standford University, Stanford, CA, USA; Department of Pathology, University of Miami, Miami, FL, USA; Department of Pathology, Mayo Clinic, Rochester, MN, USAShow moreShow less
Source PDF DOI Publisher page
84 days

Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry

Authors
Yuichiro Hatano; Kohei Taniguchi; Akihiko Toji; Shinichi Terada; Hiroki Hamamoto; Tomohito Tanaka; Sang-Woong Lee; Yoshinobu HiroseShow moreShow less
Affiliations
Department of Pathology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, Japan; Department of General and Gastroenterological Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569‐8686, JapanShow moreShow less
Source PDF DOI Publisher page
90 days

Metastatic pancreatic acinar cell carcinoma to the liver mimicking neuroendocrine tumor (NET) and pancreatic ductal adenocarcinoma (PDAC): A series of seven cases

Authors
Tiane Chen; Ralph H. Hruban; Pedram ArganiShow moreShow less
Affiliations
Departments of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Departments of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USAShow moreShow less
Source PDF DOI Publisher page
70 days

Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+/HER2− breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score

Authors
Zohre Sadeghian; Sara Rhode; Hadi Sultan; Theresa Abdo; Ahmad Alhalabi; Elvia Goez-Gutierrez; Zeina Nahleh; Esther YoonShow moreShow less
Affiliations
Department of Pathology & Laboratory Medicine, Cleveland Clinic Florida, Weston, FL, USA; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA; Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USAShow moreShow less
Source PDF DOI Publisher page
44 days

Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions

Authors
Mokhtar H. Abdelhammed; Richard K. Yang; Volha Lenskaya; Carlos A. Torres-Cabala; Woo Cheal ChoShow moreShow less
Affiliations
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAShow moreShow less
Source PDF DOI Publisher page
60 days

Clinical impact of second opinion consultation in bladder biopsies and transurethral resection of bladder tumors

Authors
Carla Calagua; Swati Bhardwaj; Veronica Ochoa Cholan; Mahsa Hojabri; Andres MatosoShow moreShow less
Affiliations
Department of Pathology, United States; Oncology, United States; Urology, The Johns Hopkins Hospital, Baltimore, MD, United States; Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, United StatesShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does HUMAN PATHOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 13 complete review records for HUMAN PATHOLOGY. The fastest paper went from submission to acceptance in 24 days (Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors, received 2026-05-29, accepted 2026-06-22); the slowest took 149 days. The average is 65.5 days and the median is 60 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.